teaser
Following a comprehensive analysis of pre- and postmarketing data by the UK’s MHRA and Commission on Human Medicines, the risk-benefit profile for rosuvastatin (Crestor
This site is intended for health professionals only
teaser
Following a comprehensive analysis of pre- and postmarketing data by the UK’s MHRA and Commission on Human Medicines, the risk-benefit profile for rosuvastatin (Crestor